Found 626 matching trials
Vaginal Estrogen for Asymptomatic Microscopic Hematuria PHASE4 The specific aim of this protocol is to determine whether vaginal estrogen ...
Show More Location
Mount Auburn Hospital
Learn More & Join Trial
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer PHASE1 The purpose of this trial is to estimate the recommended dose (RD) of \[177...
Show More Status
Active Not Recruiting
Location
UCLA Jonsson Comp Cancer Center
Learn More & Join Trial
Human Requirements for the Nutrient Choline NA The purpose of this study is to increase our understanding of how much chol...
Show More Location
University of North Carolina
Learn More & Join Trial
Alzheimer's Disease Prevention Trial PHASE3 This is a three-year study to determine if estrogens can prevent memory los...
Show More Location
University of Alabama
Learn More & Join Trial
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself. N/A A retrospective study of de-identified (to preserve patient privacy) patien...
Show More Learn More & Join Trial
Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure NA To directly compare the safety (by laboratory evaluation) and efficacy (fem...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant. PHASE1 The purpose of this study is to microscopically examine breast cancer cells...
Show More Learn More & Join Trial
Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line PHASE3 This study is designed to evaluate the efficacy and safety of first-line tr...
Show More Location
Gemeinschaftspraxis für Hämatologie und Onkologie
Learn More & Join Trial
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer PHASE3 A study to compare the safety and efficacy of an aromatase inhibitor in com...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer PHASE2 This is a randomized trial for patients with metastatic hormone receptor (H...
Show More Location
University of Alabama at Birmingham (UAB)
Learn More & Join Trial